AP-HM - Hopital de la Timone — Marseille

Public research footprint of AP-HM - Hopital de la Timone, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) · Squamous Non-Small Cell Lung Cancer (NSCLC) · Advanced or Metastatic NRAS-mutant Melanoma · Fascioscapulohumeral Muscular Dystrophy Type 1

Recently updated registry entries

NCT05291091 — Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) (Active Not Recruiting)
NCT06066580 — Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy (Enrolling By Invitation)
NCT06634420 — HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at AP-HM - Hopital de la Timone?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.